IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 22 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,705,000 | -33.2% | 27,368,000 | -30.2% | 0.01% | -25.0% |
| Q2 2023 | $39,993,116 | -24.6% | 39,187,000 | -25.6% | 0.01% | -33.3% |
| Q1 2023 | $53,014,449 | -3.9% | 52,687,000 | +5.0% | 0.01% | -7.7% |
| Q4 2022 | $55,139,857 | +9.9% | 50,187,000 | +2.0% | 0.01% | +18.2% |
| Q3 2022 | $50,193,000 | -37.5% | 49,191,000 | -34.1% | 0.01% | -47.6% |
| Q2 2022 | $80,347,000 | -8.0% | 74,691,000 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $87,368,000 | +12.1% | 74,691,000 | +8.6% | 0.02% | +12.5% |
| Q4 2021 | $77,945,000 | -6.1% | 68,788,000 | 0.0% | 0.02% | -5.9% |
| Q3 2021 | $83,045,000 | +0.9% | 68,788,000 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $82,290,000 | +5.9% | 68,788,000 | 0.0% | 0.02% | -5.3% |
| Q1 2021 | $77,681,000 | +8.8% | 68,788,000 | +9.6% | 0.02% | 0.0% |
| Q4 2020 | $71,391,000 | +37.6% | 62,788,000 | +18.9% | 0.02% | +26.7% |
| Q3 2020 | $51,877,000 | – | 52,788,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 36,225,000 | $40,606,000 | 1.41% |
| Context Capital Management, LLC | 3,000,000 | $3,378,000 | 0.46% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,808,000 | $4,308,000 | 0.45% |
| AQR Arbitrage LLC | 7,500,000 | $8,444,000 | 0.30% |
| Polar Asset Management Partners Inc. | 14,500,000 | $16,367,000 | 0.18% |
| LINDEN ADVISORS LP | 9,300,000 | $10,496,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,688,000 | 0.06% |
| Jefferies Group LLC | 2,201,000 | $2,502,527 | 0.02% |
| Citadel Advisors | 62,788,000 | $71,391,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 10,000,000 | $11,259,000 | 0.01% |